Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus

نویسندگان

  • Gerrit Koop
  • Manouk Vrieling
  • Daniel M. L. Storisteanu
  • Laurence S. C. Lok
  • Tom Monie
  • Glenn van Wigcheren
  • Claire Raisen
  • Xiaoliang Ba
  • Nicholas Gleadall
  • Nazreen Hadjirin
  • Arjen J. Timmerman
  • Jaap A. Wagenaar
  • Heleen M. Klunder
  • J. Ross Fitzgerald
  • Ruth Zadoks
  • Gavin K. Paterson
  • Carmen Torres
  • Andrew S. Waller
  • Anette Loeffler
  • Igor Loncaric
  • Armando E. Hoet
  • Karin Bergström
  • Luisa De Martino
  • Constança Pomba
  • Hermínia de Lencastre
  • Karim Ben Slama
  • Haythem Gharsa
  • Emily J. Richardson
  • Edwin R. Chilvers
  • Carla de Haas
  • Kok van Kessel
  • Jos A. G. van Strijp
  • Ewan M. Harrison
  • Mark A. Holmes
چکیده

Bicomponent pore-forming leukocidins are a family of potent toxins secreted by Staphylococcus aureus, which target white blood cells preferentially and consist of an S- and an F-component. The S-component recognizes a receptor on the host cell, enabling high-affinity binding to the cell surface, after which the toxins form a pore that penetrates the cell lipid bilayer. Until now, six different leukocidins have been described, some of which are host and cell specific. Here, we identify and characterise a novel S. aureus leukocidin; LukPQ. LukPQ is encoded on a 45 kb prophage (ΦSaeq1) found in six different clonal lineages, almost exclusively in strains cultured from equids. We show that LukPQ is a potent and specific killer of equine neutrophils and identify equine-CXCRA and CXCR2 as its target receptors. Although the S-component (LukP) is highly similar to the S-component of LukED, the species specificity of LukPQ and LukED differs. By forming non-canonical toxin pairs, we identify that the F-component contributes to the observed host tropism of LukPQ, thereby challenging the current paradigm that leukocidin specificity is driven solely by the S-component.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Detection of Novel Mutation in LukS Panton-Valentine Leukocidin Gene in Twelve Isolates of Staphylococcus aureus from Sudanese Patients

Staphylococcus aureus carrying PVL gene remain major health problem associated with highly virulent infections. Characterization of such gene is important to know the impact and the functional significance of nucleotide variations. PCR and standard sequencing were performed for twelve Sudanese strains from different sources. Protein structures prediction, modeling and physiochemical analysis we...

متن کامل

شناسایی ژن‌های حدت پنتون ‌والنتین لوکوسیدین (PVL) و مقاومت به متی‌سیلین (mecA ) در استافیلوکوکوس اورئوس جدا شده از نمونه‌های بالینی‌: یک گزارش کوتاه

Background and Objective: Staphylococcus aureus is a major pathogen of human in the world. Methicillin-resistant Staphylococcus aureus is associated with nosocomial infections. Recently, staphylococcal infections have been associated with the community. The purpose of this study was to isolate and identify Staphylococcus aureus virulence Panton-Valentine leukocidin (PVL) and  methicillin...

متن کامل

Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.

Staphylococcus aureus (S. aureus) is a human pathogen that relies on the subversion of host phagocytes to support its pathogenic lifestyle. S. aureus strains can produce up to five beta-barrel, bi-component, pore-forming leukocidins that target and kill host phagocytes. Thus, preventing immune cell killing by these toxins is likely to boost host immunity. Here, we describe the identification of...

متن کامل

Crystal structures of the components of the Staphylococcus aureus leukotoxin ED

Staphylococcal leukotoxins are a family of β-barrel, bicomponent, pore-forming toxins with membrane-damaging functions. These bacterial exotoxins share sequence and structural homology and target several host-cell types. Leukotoxin ED (LukED) is one of these bicomponent pore-forming toxins that Staphylococcus aureus produces in order to suppress the ability of the host to contain the infection....

متن کامل

A new approach to toxin neutralization in Staphylococcus aureus therapy.

Staphylococcus aureus is a significant human pathogen responsible for a range of diseases including pneumonia, sepsis, skin, and soft tissue infections. An important component of its success as a human pathogen is the production of a large array of virulence factors including several toxins. In this issue of EMBO Reports, Reyes-Robles and colleagues [1] identify a glycine-rich motif shared by b...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 7  شماره 

صفحات  -

تاریخ انتشار 2017